PALO ALTO, Calif. – October 30, 2024
Strategic Collaboration to Accelerate Clinical Research
Medable Inc., a leader in digital and decentralized clinical trial technologies, has formed a strategic partnership with Google Cloud to launch its AI-enabled clinical trials platform on Google Cloud Marketplace. This collaboration increases access to Medable’s tools and allows life sciences companies to leverage Google Cloud’s secure infrastructure and AI capabilities to streamline clinical development.
Introducing Medable Studio: AI-Powered Trial Management
As part of this partnership, Medable is unveiling Medable Studio, a SaaS solution designed to enhance control over clinical trial design, execution, and management. Integrated with Google Cloud’s global platform, Studio is aimed at reducing trial timelines while boosting operational efficiency for pharmaceutical companies.
Seamless Integration & Scalable Deployment
With Medable’s platform now available through Google Cloud Marketplace, life sciences organizations can easily acquire and deploy the solution within their existing cloud environments. Key benefits include:
- Accelerated Clinical Trial Execution – AI-driven workflows that improve study design and patient engagement.
- Simplified Procurement & Billing – Streamlined purchasing with the option to use Google Cloud committed spend.
- Enterprise-Level Scalability – Flexible deployment in hybrid cloud settings for optimized operations.
“Making Medable’s platform available on Google Cloud Marketplace will help customers quickly scale AI-powered clinical trials while benefiting from Google Cloud’s secure and compliant infrastructure,” said Dai Vu, Managing Director, Marketplace & ISV GTM Programs at Google Cloud.
Driving Efficiency with AI & Cloud Technology
The partnership between Medable and Google Cloud is designed to deliver substantial efficiency improvements. Reported benefits include:
- 200% faster patient enrollment
- 50% reduction in trial costs
- Up to $39 million in ROI for Phase III trials, according to a Tufts CSDD study.
Enhancing Global Patient Access to Clinical Trials
This initiative further strengthens Medable’s mission to modernize research practices and expand patient access globally.
“By integrating with Google Cloud, we are making it easier for life sciences organizations to adopt Medable’s platform at scale, accelerating drug development while enhancing patient participation worldwide,” said Dr. Michelle Longmire, CEO and Co-founder of Medable.
Learn More at Google Cloud’s Cancer AI Symposium
Medable will share more about this partnership at Google Cloud’s inaugural Cancer AI Symposium in Boston on October 30, 2024, where Dr. Longmire will speak.
About Medable
Medable’s digital clinical trials platform is transforming the clinical research landscape by increasing speed, scalability, and patient access. Recognized by the Galien Foundation as the Best Digital Health Solution, Medable’s technology has supported nearly 400 trials across 70 countries, reaching over one million patients. Headquartered in Palo Alto, California, the company is a two-time Inc. 5000 honoree.
More about this news
By